EAN 2023 | Advances in genetic research and precision medicine in epileptology

Genetics has become increasingly relevant in the field of epileptology. Guido Rubboli, MD, University of Copenhagen, Copenhagen, Denmark, notes that many epileptic conditions, particularly those with childhood onset, have been attributed to pathogenic gene variants. This holds significance as it enables the pursuit of precision medicine approaches aimed at correcting these genetic defects. Numerous ongoing studies are investigating existing drugs or developing new pharmaceuticals tailored towards specific genetic abnormalities associated with epilepsy. However, many of these epileptic conditions linked to genetic abnormalities are rare, resulting in small patient cohorts. Additionally, there is a lack of systematic research direction in gene selection. Overall, the field of precision medicine for epileptic conditions is in its early stages, necessitating improvements in research design to yield more robust results. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.